WallStSmart

Churchill Capital Corp XI (CCXI)vsNew America Acquisition I Corp. (NWAX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

NWAX leads profitability with a 0.0% profit margin vs 0.0%. CCXI earns a higher WallStSmart Score of 24/100 (F).

CCXI

Avoid

24

out of 100

Grade: F

Growth: 4.3Profit: 4.0Value: 5.0Quality: 6.0
Piotroski: 2/9

NWAX

Avoid

21

out of 100

Grade: F

Growth: 4.3Profit: 4.0Value: 5.0Quality: 4.5
Piotroski: 2/9

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCXI0 strengths · Avg: 0/10

No standout strengths identified

NWAX0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

CCXI4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$1.06B3/10

Smaller company, higher risk/reward

Return on EquityProfitability
4.7%3/10

ROE of 4.7% — below average capital efficiency

NWAX4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$504.72M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.1%3/10

ROE of 0.1% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : CCXI

CCXI has a balanced fundamental profile.

Bull Case : NWAX

NWAX has a balanced fundamental profile.

Bear Case : CCXI

The primary concerns for CCXI are Revenue Growth, EPS Growth, Market Cap.

Bear Case : NWAX

The primary concerns for NWAX are Revenue Growth, EPS Growth, Market Cap.

Key Dynamics to Monitor

NWAX is growing revenue faster at 0.0% — sustainability is the question.

NWAX generates stronger free cash flow (-88,580), providing more financial flexibility.

Monitor SHELL COMPANIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CCXI scores higher overall (24/100 vs 21/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Churchill Capital Corp XI

FINANCIAL SERVICES · SHELL COMPANIES · USA

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.

New America Acquisition I Corp.

FINANCIAL SERVICES · SHELL COMPANIES · USA

New America Acquisition I Corp. (NWAX) is a forward-looking special purpose acquisition company (SPAC) focused on merging with high-growth, innovative businesses across various sectors. With a seasoned management team adept in corporate finance and operational strategy, NWAX aims to create substantial value by facilitating the transition of promising private companies to the public markets. Leveraging emerging market trends and strategic alliances, NWAX positions itself to capitalize on investment opportunities that promise attractive returns and enhanced long-term shareholder value in a rapidly evolving landscape.

Want to dig deeper into these stocks?